WhisperFromWallStreet PWRV Alert

Hello All,

Our newest alert has been busy making big announcements all spring.

It is also trading toward the low end of its range, which makes it look like it could possibly make a nice move from here.

Our alert for Monday is Power of the Dream Ventures Inc., PWRV, and the stock closed Friday at 33 cents.

Please begin your research here www.powerofthedream.com and here http://finance.yahoo.com/q?s=PWRV.OB&ql=0

Here is some information to get you started.

PWRV is an extremely unique company working on acquiring, investing in, and developing intellectual properties originating in the Republic of Hungary.

Since our last coverage on PWRV the company has issued a number of significant press releases.

In March PWRV announced an investment agreement with Genetic Immunity (GI). GI has developed and patented immune therapy technology for a number of critical diseases. Their lead product candidate is called Dermavir, a vaccine for the treatment of HIV.
In their Phase 2 human clinical trials Dermavir demonstrated median 70% viral load reduction in patients without any side effect. This is extremely significant news. PWRV will assist GI complete a listing in the United States and raise $25 million to complete Phase 2 trials and get marketing approval for Dermavir. GI will also initiate additional Phase I trials for more products based on the technology behind DermaVir. PWRV received 14% equity in the company and Warrants to acquire an additional 3 million shares.
Once GI begins trading PWRV will provide a dividend to its shareholders in GI common stock. At the time GI begins trading the company will have approximately 17 million shares issued and outstanding, giving PWRV over 20% equity with Warrants. The HIV field currently generates over $12 billion in revenue on a worldwide basis. Dermavir is aimed at entering this field with a highly effective, side effects free product.

PWRV also announced that two executive officers of the company will convert a total of 24 million common shares into preferred shares, reducing issued and outstanding by over 40%. PWRV’s currently issued shares count of a bit over 53 million, after the conversion PWRV will only have less than 30 million outstanding.

In April PWRV announced that Genetic Immunity has signed a therapeutic vaccine development agreement with Europe’s Fraunhofer Institute in Germany to develop a vaccine against the West Nile Virus based on Genetic Immunity’s platform technology. With Phase 2 HIV results already out this agreement provides third party verification of GI’s technology.

PWRV then announced that the company’s other main investment in iGlue has also reached a significant milestone. iGlue launched the company’s main product with its social media extensions.
PWRV announced the official Phase 2 results of Genetic Immunity’s Dermavir, demonstrating 7ö% viral load reduction without side effects. Independent data from an ACTG (Aids Clinical Trial Group) conducted US based Phase I/II trial is also to be presented this June.

Also in April PWRV announced a Going Public roadmap for iGlue. As part of this plan PWRV will arrange and assist iGlue become a publicly traded company in the United States. As part of this going public roadmap, once iGlue is public, PWRV will provide a 50% share dividend to PWRV shareholders in iGlue common stock. This one step can results in multi fold return to PWRV shareholders.

In May PWRV announced what they call ‘The iGlue Summer Annotation Challenge’ a cash and prizes competition aimed at rewarding iGlue users who bring added value to iGlue’s revolutionary semantic search and annotation technology. Whoever annotates, correctly, the most words on select websites wins the first, second and third prizes. The company will also have a number of additional items to reward users.

PWRV launched this competition last week.

Coincidentally, concurrent with the launch, one of the world’s leading internet technology blogs, Techcrunch, covered the Annotation Challenge. This shows international interest in the product.

The editorial written by Techcrunch.com is here:

http://eu.techcrunch.com/2011/06/01/iglue-challenges-users-to-wikify-the-web-with-40k-in-cash-prizes/

And last but not least, since our last coverage, Gene Guhne, Director of the company, has acquired over 100,000 shares on the open market. This is in addition to the over 1,7 million shares CEO Viktor Rozsnyay has acquired on the open market. Also of note. Gene Guhne is Vice President of Sales at Ultimate Software, a NASDAQ traded $1.4B dollar company. If Mr. Guhne believes it is worth sitting on PWRV’s Board of Directors PWRV is worth following and investing in.

As you can see PWRV has been extremely busy announcing major news items within the last 60 days, executives who buy on the open
market, and products that are emerging after years of research.

PWRV is currently trading at the lower end of its trading range.

Over the last 2 years the company has traded as high as $4 dollars and as low as $0.02 cents.

If PWRV headed back to it’s highs that would be over a 1000% price gain from these levels.

As always, do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.

Good Trading,

WhisperFromWallStreet

If you do not trade with a broker that allows stops GET ONE.
ChoiceTrades does allow stops and they only charge $5 commissions on OTC stocks. Open an account by following this link.

http://wfwsconsulting.com/choicetrades

We can be found on Facebook at

http://www.facebook.com/WhisperFromWallStreet

IMPORTANT NOTICE AND DISCLAIMER

WFWS Consulting Inc. is an information and marketing firm and is not a financial analyst, investment advisor or broker/dealer. We are in the business of marketing and advertising companies to generate exposure of them by sending alerts to our subscribers for monetary compensation.

The content of this e-mail sent by WFWS Consulting Inc. is paid advertising and does not purport to provide an analysis of the featured company’s financial position, operations or prospects.

Because this advertisement has not been prepared with any one individuals financial condition or investment goals in mind it is not to be construed as a recommendation or solicitation by WFWS Consulting Inc. to buy or sell any security.

WFWS Consulting Inc. has been paid $40,000 cash by Cobalt Blue LLC.
for the purpose of increasing public awareness of PWRV.

WFWS has not investigated the background of the hiring company.
Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own shares of the company mentioned which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price.

Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company’s stock during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.

Investing in securities is highly speculative and carries a great deal of risk, especially as to newer companies with comparatively short operating histories and limited earnings. You may lose your entire investment. If you cannot afford to lose your entire investment do NOT invest in penny stocks.

WFWS has no relationship with ChoiceTrades.com other than a one-time referral fee if a reader clicks on our link and becomes a client of ChoiceTrades.com. WFWS relies upon the accounting of such fees furnished to it by ChoiceTrades.com but has no access to the identity or account information of any such person(s).

WFWS Consulting Inc. nor any of its officers or principals or affiliates (as defined in the Securities Act of thirty three, as amended, and Rule 501(b) promulgated thereunder) will never own or beneficially own any securities of any company mentioned in this email. We are advertisers, not investors or traders.

This advertisement is based entirely upon information gathered from public information and third party websites. Although the information contained in this e-mail is believed to be reliable, WFWS Consulting Inc. makes no warranties as to the accuracy of the content of this e-mail, expressly disclaims and accepts no liability for how readers may choose to utilize the content of this e-mail. Readers are strongly urged to independently verify all statements made in this advertisement and to perform their own due diligence on this or any other advertised company, including but not limited to consulting with a qualified investment professional, reviewing the publicly available financial statements of, and other information about these featured companies and verifying that an investment in that company is appropriate and suitable for you.

Featured companies are traded on the OTC Bulletin Board or Pink Sheets and their stock is registered under the Securities Act of thirty three, as amended, and its periodic and other reports filed under the Securities Exchange Act of thirty four, as amended, are publicly available from the Securities and Exchange Commission at its website at http://www.sec.gov, which also contains general investor information about publicly-traded companies, advice to investors and other investor resources. Other investor resources are available from the Financial Industry Regulatory Authority through its website at http://www.finra.org.

Many states have established rules requiring approval by the state securities administrator to permit sales of a security to its residents. Check with the North American Securities Administrators Association through its website at http://www.nasaa.org or call your state securities administrator to determine whether a particular security may be purchased by you as a resident of your state. Many companies have filed information with state securities regulators and many companies will supply prospective investors with additional information upon request.

This advertisement contains forward-looking statements about the featured company its business and prospects. Such forward-looking statements are within the meaning of Section Twenty Seven A of the Securities Act of thirty three, as amended, and Section Twenty One E of the Securities Exchange Act of thirty four, as amended, and are intended to be covered by the safe harbor provisions created by these laws. Where a featured company expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis.
However, forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements.